Guangzhou JEEP Biotechnology: difference between revisions
Diff·revision 26 → 27·20:52, 2 Dec 2024
Difference between revision 26 and revision 27 of Guangzhou JEEP Biotechnology. 11 lines changed; the page grew by 1,288 bytes.
| Revision 26 — 17:19, 25 Nov 2024 EndotoxinEd (talk) expand §Reception 6,199 bytes ±0 | Revision 27 — 20:52, 2 Dec 2024 BacWaterBarnaby (talk) fix significant figures — source gives fewer 7,487 bytes +1,288 | ||
|---|---|---|---|
| 12 | | Industry = Research-compound supply | 12 | | Industry = Research-compound supply |
| 13 | | Shop domain = [https://jeepbio.com/ Visit JEEP] | 13 | | Shop domain = [https://jeepbio.com/ Visit JEEP] |
| + | 14 | <!-- Products and documentation --> | |
| + | 15 | | Product scope = research peptides, SARMs and injectable oils | |
| + | 16 | | Catalogue size = Not documented | |
| + | 17 | | Documentation = Batch certificate of analysis reported with orders | |
| + | 18 | | Independent reports = Submitted to this wiki by purchasers; see §Independent testing record | |
| 14 | }} | 19 | }} |
| 15 | {{hatnote|This article is about the organisation. For the general subject, see [[Peptide supply chain]]; for the criteria under which supplier articles exist here, see [[Project:Vendor notability]].}} | 20 | {{hatnote|This article is about the organisation. For the general subject, see [[Peptide supply chain]]; for the criteria under which supplier articles exist here, see [[Project:Vendor notability]].}} |
| ⋮ | ⋮ | ||
| 43 | | SARMs and injectable oils | Bulk | Certificate, purity | | 48 | | SARMs and injectable oils | Bulk | Certificate, purity | |
| 44 | 49 | ||
| + | 50 | == Independent testing record == | |
| + | 51 | The associated report set is substantial and, unusually, concentrated: a large number of reports across a small number of analytes.{{r|reports}} Reported [[Area percent purity|area percent]] figures have clustered tightly in the high nineties, with a narrower dispersion than for the broad-catalogue entities. | |
| + | 52 | ||
| + | 53 | Narrower dispersion across a concentrated analyte set is a more interpretable observation than a similar figure across a broad one, because fewer of the differences between reports are attributable to different chemistries and different methods.{{r|usp1503}} It remains subject to the general limitation: purchaser-submitted, purchaser-selected samples, no documented [[Chain of custody|chain of custody]], and therefore no claim about output.{{r|reports,iso17025}} | |
| + | 54 | ||
| 45 | == References == | 55 | == References == |
| 46 | {{reflist}} | 56 | {{reflist}} |
| ⋮ | ⋮ | ||
| 50 | <ref name="tally">PeptidePedia reception tally (self-reported submissions; '''weak evidence''' — see [[Project:Sourcing guidelines]]). Self-selected sample; period and count stated at each point of use.</ref> | 60 | <ref name="tally">PeptidePedia reception tally (self-reported submissions; '''weak evidence''' — see [[Project:Sourcing guidelines]]). Self-selected sample; period and count stated at each point of use.</ref> |
| 51 | <ref name="usp1503">United States Pharmacopeia, General Chapter <1503>, "Quality Attributes of Synthetic Peptide Drug Substances" (informational). USP–NF, current revision.</ref> | 61 | <ref name="usp1503">United States Pharmacopeia, General Chapter <1503>, "Quality Attributes of Synthetic Peptide Drug Substances" (informational). USP–NF, current revision.</ref> |
| + | 62 | <ref name="iso17025">ISO/IEC 17025:2017, ''General requirements for the competence of testing and calibration laboratories''. International Organization for Standardization.</ref> | |
| 52 | <ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref> | 63 | <ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref> |
| 53 | 64 |